Giuseppe Lippi/LinkedIn
Mar 14, 2026, 12:59
Giuseppe Lippi: New Highlights on Key Aspects of Heparin Anticoagulant Therapy and Monitoring
Giuseppe Lippi, Professor at University of Verona, Dean at Faculty of Medicine and Surgery, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Happy to share our new article on ‘Heparin Anticoagulant Therapy and Its Monitoring’.”
Title: Heparin Anticoagulant Therapy and Its Monitoring
Authors: Benjamin Reardon, Leonardo Pasalic, Giuseppe Lippi, Emmanuel J. Favaloro
Read the Full Article on Biomolecules
See more in the gallery.
Other posts featuring Giuseppe Lippi on Hemostasis Today.
-
Jun 21, 2026, 16:33Dua Asim: Efficacy and Safety of Rivaroxaban Plus Aspirin in PAD Patients
-
Jun 21, 2026, 16:21Early Gains in Stroke Knowledge With Stroke Riskometer – International Journal of Stroke
-
Jun 21, 2026, 16:12Cost Savings and Reduced Factor Consumption With Efanesoctocog Alfa – Blood Journals Portfolio
-
Jun 21, 2026, 15:59John Jaksich: Heparin and Anticoagulants – Chemistry, Biotechnology, and Manufacturing
-
Jun 21, 2026, 15:11Mishal Khan: Long-Term Mortality Trends and Demographic Disparities in Patients With PE and AF
-
Jun 21, 2026, 14:57Vimal Koshy Thomas: Adding to the Evidence Base for Endovascular Therapy Beyond 24 Hours
-
Jun 21, 2026, 14:57Abdul Mannan: Integrating Female Reproductive Health into Lifelong Haematology Care
-
Jun 21, 2026, 14:56Ayoub Ait Lahcen: Can We Reduce Blood Transfusions in Cardiac Surgery Before the Operation Even Begins?
-
Jun 21, 2026, 14:38Christina (Tina) P: Staying Safe on Anticoagulation Therapy in Antiphospholipid Syndrome